OPACE collaboration will be across the UK, at primary (GP practices) and secondary sites (hospitals). PIC sites are welcome too. Active participating sites can be found here.
If you are a potential participant, please contact the OPACE clinical trial team at your local GP or hospital site in the first instance.
For General enquiries please contact: [email protected]
As of 26th Sep 2023, we are pleased to confirm final approvals have been received from the Medicines and Healthcare products Regulatory Agency (MHRA), the Research Ethics Committee (REC), and Health Research Authority (HRA) for the OPACE trial to proceed. What happens next? Following approvals, we can start initiating and activating sites to begin […]